82 related articles for article (PubMed ID: 3184469)
1. [bcr rearrangement in variant Ph1-positive chronic myelocytic leukemia and unclassified myeloproliferative disorders].
Sekito N; Takahashi I
Rinsho Ketsueki; 1988 Jul; 29(7):1018-24. PubMed ID: 3184469
[No Abstract] [Full Text] [Related]
2. [bcr rearrangement in variant Ph1-positive chronic myelocytic leukemia].
Sekito N; Takahashi I; Takeuchi M; Osada K; Hayashi N; Aoyama S; Fujimoto S; Yorimitsu S; Kimura I; Sanada H
Nihon Ketsueki Gakkai Zasshi; 1988 Aug; 51(5):864-71. PubMed ID: 3206984
[No Abstract] [Full Text] [Related]
3. [Molecular biologic study in chronic myelogenous leukemia and its related disorders].
Ohyashiki JH; Ohyashiki K; Toyama K
Rinsho Ketsueki; 1988 Jul; 29(7):1010-7. PubMed ID: 3184468
[No Abstract] [Full Text] [Related]
4. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.
Farhi DC; Luckey CN; Siddiqui AM
Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936
[TBL] [Abstract][Full Text] [Related]
5. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
6. Abnormal chromatin clumping in granulocytes in a case of Ph1-negative, BCR-ABL rearrangement positive, haematologically atypical chronic myeloid leukaemia (CML).
Tertian G; Misrahi M; Diallo D; Mielot F; Leonard C; Salmeron S; Tchernia G
Nouv Rev Fr Hematol (1978); 1995; 37(4):245-7. PubMed ID: 8904205
[TBL] [Abstract][Full Text] [Related]
7. Bcr-abl mRNA expression in patients with chronic myeloproliferative disorders--absence of bcr-abl fused clone except chronic myelocytic leukemia.
Nakata Y
Hiroshima J Med Sci; 1993 Jun; 42(2):67-71. PubMed ID: 8253600
[TBL] [Abstract][Full Text] [Related]
8. Two case reports of 1q triplication in myeloproliferative neoplasms.
Park TS; Lee SG; Cheong JW; Song J; Lee KA; Kim J; Yoon S; Choi JR
Cancer Genet Cytogenet; 2009 Jun; 191(2):111-2. PubMed ID: 19446749
[No Abstract] [Full Text] [Related]
9. Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogeneous leukemia.
Richebourg S; Theisen O; Plantier I; Parry A; Soenen-Cornu V; Lepelley P; Preudhomme C; Renneville A; Laï JL; Roche-Lestienne C
Genes Chromosomes Cancer; 2008 Oct; 47(10):915-8. PubMed ID: 18615682
[No Abstract] [Full Text] [Related]
10. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
[TBL] [Abstract][Full Text] [Related]
11. A variant Philadelphia chromosome (Ph1) positive chronic myelocytic leukemia.
Haruta Y; Takahashi I; Sekito N; Miyamoto K; Shimamoto M; Wakita Y; Kikkawa K; Nakamura T; Seto T; Yamashita J
Acta Med Okayama; 1990 Oct; 44(5):283-6. PubMed ID: 2260501
[TBL] [Abstract][Full Text] [Related]
12. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.
So CC; Ma ES; Wan TS; Yip SF; Chan LC
Leuk Res; 2008 Jun; 32(6):1000-1. PubMed ID: 17980911
[No Abstract] [Full Text] [Related]
14. [Unclassified chronic myeloproliferative disorder (Ph negative/bcr rearrangement negative CML) with late appearing Philadelphia like chromosome].
Hamada K; Takahashi I; Saika T; Komatsu M; Yorimitsu S; Urata T; Sunami K
Rinsho Ketsueki; 1996 Mar; 37(3):221-7. PubMed ID: 8727346
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in biological and therapeutic aspects of myeloproliferative disorders.
Mancini M; Diverio D; Alimena G; Mandelli F
Curr Opin Hematol; 1994 Jul; 1(4):261-7. PubMed ID: 9371292
[TBL] [Abstract][Full Text] [Related]
16. [Two cases of unclassified chronic myeloproliferative disorders].
Hirano A; Takahashi I; Haruta Y; Nakamura T; Nakata H; Yorimitsu S; Sekito N; Kimura I
Rinsho Ketsueki; 1992 Apr; 33(4):525-31. PubMed ID: 1602619
[TBL] [Abstract][Full Text] [Related]
17. Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia.
Costa D; Carrió A; Madrigal I; Arias A; Valera A; Colomer D; Aguilar JL; Teixido M; Camós M; Cervantes F; Campo E
Cancer Genet Cytogenet; 2006 Apr; 166(1):89-93. PubMed ID: 16616117
[TBL] [Abstract][Full Text] [Related]
18. A masked BCR/ABL rearrangement in a case of chronic myeloid leukemia with translocation t(3;9)(p14;q34).
Bennour A; Sennana H; Laatiri MA; Khelif A; Saad A
Cancer Genet Cytogenet; 2008 Feb; 181(1):72-4. PubMed ID: 18262060
[No Abstract] [Full Text] [Related]
19. [Cytogenetic studies on myeloproliferative disorder].
Taniwaki M; Misawa S
Rinsho Ketsueki; 1988 Jul; 29(7):1001-9. PubMed ID: 3184467
[No Abstract] [Full Text] [Related]
20. Chronic myeloproliferative disorders--introduction.
Skoda R; Prchal JT
Semin Hematol; 2005 Oct; 42(4):181-3. PubMed ID: 16210031
[No Abstract] [Full Text] [Related]
[Next] [New Search]
